Myocyte apoptosis: Programming ventricular remodeling

Journal of the American College of Cardiology

Volumn 41, Issue 5, 2003, Pages 761-764

  Mani, Kartik ^a   Kitsis, Richard N ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3;

APOPTOSIS; ENZYME ACTIVATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE NECROSIS; HEART VENTRICLE REMODELING; HEART VENTRICLE WALL; HUMAN; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PEER REVIEW; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK FACTOR;

EID: 0037420108     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02958-3     Document Type: Editorial

References (34)

1. AHA. 2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2002:11-14.
2. Abbate A, Biondi-Zoccai GGL, Bussani R, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 2003;41:753-60.
3. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
4. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-8.
5. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-6.
6. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8.
7. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
8. Bialik S, Geenen DL, Sasson IE, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 1997;100:1363-72.
9. Jeremias I, Kupatt C, Martin-Villalba A, et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 2000;102:915-20.
10. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, Kitsis RN. The Fas pathway is a critical mediator of cardiac myocyte death and myocardial infarction during ischemia/reperfusion in vivo. Am J Physiol Heart Circ Physiol 2002. In Press.
11. Cheng W, Kajstura J, Nitahara JA, et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 1996;226:316-27.
12. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79:949-56.
13. Olivetti G, Quaini F, Sala R, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005-16.
14. Palojoki E, Saraste A, Eriksson A, et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2001;280:H2726-31.
15. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-62.
16. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000;35:569-82.
17. Sam F, Sawer DB, Chang DL, et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 2000;279:H422-8.
18. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41.
19. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-3.
20. Guerra S, Leri A, Wang X, et al. Myocyte death in the failing human heart is gender dependent. Circ Res 1999;85:856-66.
21. Saraste A, Pulkki K, Kallajoki M, et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 1999;29:380-6.
22. Hayakawa K, Takemura G, Koda M, et al. Sensitivity to apoptosis signal, clearance rate, and ultrastructure of Fas ligand-induced apoptosis in in vivo adult cardiac cells. Circulation 2002;105:3039-45.
23. de Moissac D, Gurevich RM, Zheng H, Singal PK, Kirshenbaum LA. Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 2000;32:53-63.
24. Suzuki K, Kostin S, Person V, Elsasser A, Schaper J. Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes. J Mol Cell Cardiol 2001;33:983-94.
25. Wencker D, Chandra M, Armstrong RC, et al. Rescue of dilated cardiomyopathy by caspase inhibition in FKBP-caspase-8 transgenic mice. In: Willerson JT, editor. Scientific Sessions 2000. New Orleans, LA: Lippincott, Williams and Wilkins, 2000:II8.
26. Brocheriou V, Hagege AA, Oubenaissa A, et al. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med 2000;2:326-33.
27. Miao W, Luo Z, Kitsis RN, Walsh K. Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. J Mol Cell Cardiol 2000;32:2397-402.
28. Matsui T, Tao J, del Monte F, et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001;104:330-5.
29. Peng CF, Lee P, Deguzman A, et al. Multiple independent mutations in apopotic signaling pathways markedly decrease infarct size due to myocardial ischemia-reperfusion. In: Willerson JT, editor. Scientific Sessions 2001. Anaheim, CA: Lippincott Williams & Wilkins, 2001:II187.
30. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 2001;280:H2313-20.
31. Chatterjee S, Stewart AS, Bish LT, et al. Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure. Circulation 2002;106:I212-7.
32. Hayakawa Y, Chandra M, Miao W, et al. Caspase inhibition improves cardiac function and completely rescues mortality in the lethal peripartum cardiomyopathy of Galphaq transgenic mice. In: Willerson JT, editor. Scientific Sessions 2001. Anaheim, CA: Lippincott, Williams and Wilkins, 2001:187.
33. Abbate A, Bussani R, Biondi-Zoccai GG, et al. Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction. Circulation 2002;106:1051-4.
34. Baldi A, Abbate A, Bussani R, et al. Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 2002;34:165-74.